AbstractObjectiveThe purpose of this work was to compare measured and estimated volumetry prior to liver resection.MethodsData for consecutive patients submitted to major liver resection for colorectal liver metastases at two centres during 2004–2012 were reviewed. All patients underwent volumetric analysis to define the measured total liver volume (mTLV) and measured future liver remnant ratio (mRFLR). The estimated total liver volume (eTLV) standardized to body surface area and estimated future liver remnant ratio (eRFLR) were calculated. Descriptive statistics were generated and compared. A difference between mRFLR and eRFLR of ±5% was considered clinically relevant.ResultsData for a total of 116 patients were included. All patients unde...
International audienceFor three decades, portal vein embolization (PVE) has been the "gold-standard"...
Objectives. Portal vein embolization (PVE) stimulates hypertrophy of the future liver remnant (FLR) ...
Liver resection represents the first choice of treatment for primary and secondary liver malignancie...
AbstractObjectiveThe purpose of this work was to compare measured and estimated volumetry prior to l...
AbstractObjectivesAccurate prediction of safe remnant liver volume to minimize complications followi...
Objective(s): This study aimed to determine the effect of preoperative liver volumetry on postoperat...
Background. There is no agreement regarding the preoperative measurement of liver volumes and the mi...
Background: Hepatic resection is used increasingly for the management of a variety of benign and mal...
The aim of this study is to identify the minimum safe amount of effective remnant liver volume (ERLV...
Background: Future remnant liver volume is used to predict the risk for liver failure in patients wh...
AbstractObjectivesThe actual future liver remnant (aFLR) is calculated as the ratio of remnant liver...
Post hepatectomy liver failure (PHLF) remains a significant cause of morbidity and mortality after m...
Background: This study evaluated the safety of portal vein embolization (PVE), its impact on future...
To clarify the relationship between resected (RSV) or remnant hepatic volume (RMV) in major hepatect...
Background: One of the major causes of perioperative mortality of patients undergoing major hepatic ...
International audienceFor three decades, portal vein embolization (PVE) has been the "gold-standard"...
Objectives. Portal vein embolization (PVE) stimulates hypertrophy of the future liver remnant (FLR) ...
Liver resection represents the first choice of treatment for primary and secondary liver malignancie...
AbstractObjectiveThe purpose of this work was to compare measured and estimated volumetry prior to l...
AbstractObjectivesAccurate prediction of safe remnant liver volume to minimize complications followi...
Objective(s): This study aimed to determine the effect of preoperative liver volumetry on postoperat...
Background. There is no agreement regarding the preoperative measurement of liver volumes and the mi...
Background: Hepatic resection is used increasingly for the management of a variety of benign and mal...
The aim of this study is to identify the minimum safe amount of effective remnant liver volume (ERLV...
Background: Future remnant liver volume is used to predict the risk for liver failure in patients wh...
AbstractObjectivesThe actual future liver remnant (aFLR) is calculated as the ratio of remnant liver...
Post hepatectomy liver failure (PHLF) remains a significant cause of morbidity and mortality after m...
Background: This study evaluated the safety of portal vein embolization (PVE), its impact on future...
To clarify the relationship between resected (RSV) or remnant hepatic volume (RMV) in major hepatect...
Background: One of the major causes of perioperative mortality of patients undergoing major hepatic ...
International audienceFor three decades, portal vein embolization (PVE) has been the "gold-standard"...
Objectives. Portal vein embolization (PVE) stimulates hypertrophy of the future liver remnant (FLR) ...
Liver resection represents the first choice of treatment for primary and secondary liver malignancie...